Thu.Sep 16, 2021

Amgen to advance KRAS drug combination after improved results in colon cancer

Bio Pharma Dive

Combining Amen's Lumakras with its drug Vectibix appeared to work better in treating colorectal cancer than Lumakras alone, spurring the biotech to unveil plans for a new Phase 3 trial

Trials 220

PhRMA buys politicians and patients lose

World of DTC Marketing

SUMMARY: Three House Democrats on a key committee voted against the measure to lower drug prices as PhRMA ramped up its lobbying dollars to buy politicians.

Drugs 208
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Takeda wins FDA approval for targeted lung cancer drug

Bio Pharma Dive

Exkivity follows Johnson & Johnson's Rybrevant on the market for treating lung tumors harboring specific mutations in the EGFR gene. Unlike J&J's drug, however, Takeda's is given orally

COVID-19 is evolving to get better at becoming airborne, new study shows

Scienmag

Results of a new study led by the University of Maryland School of Public Health show that people infected with the virus that causes COVID-19 exhale infectious virus in their breath – and those infected with the Alpha variant (the dominant strain circulating at the time this study was conducted) put 43 to 100 times […].

How pharmacists can partner with health coaches

Pharma Mirror

What is a health coach? A health coach is someone with expertise in wellness who assists people achieve good health by being a mentor and educator on lifestyle and nutritional changes.

80

Researchers infuse bacteria with silver to improve power efficiency in fuel cells

Scienmag

UCLA-led?team team of?engineers engineers and chemists has taken a major step forward in the development of?microbial?fuel microbial?fuel fuel cells — a technology that?utilizes?natural utilizes?natural

Pfizer UK, Entia partner on home blood monitoring device for breast cancer patients

Pharma Times

Through Entia’s virtual oncology platform, patients are able to perform their own blood tests

99

More Trending

FDA approves IND application for peanut allergy drug candidate

Outsourcing Pharma

The US agency has given the go-ahead to Cour Pharmaceuticals to evaluate the safety and efficacy of CNP-201, a drug intended to treat peanut allergies. Markets & Regulations

Ahead of FDA adcomm, Pfizer, Moderna say COVID jab efficacy dips

Pharma Phorum

Pfizer and Moderna have both reported data that they say backs up the need for booster shots of their COVID-19 vaccines ahead of an FDA advisory committee meeting tomorrow, although the regulator seems less convinced.

Research Roundup: Link Between Herpes Simplex Virus and Neurogenerative Diseases Gets More Support

BioSpace

Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones

Takeda gets a win for its Wave1 pipeline, as Exkivity nabs FDA approval

Pharma Phorum

Takeda has had a run of bad luck with its Wave1 pipeline of new drug candidates of late, but can now celebrate a vestry after getting FDA approval for first-in-class lung cancer therapy Exkivity.

Vifor Licenses Rare Kidney Disease Drug in Comeback for Travere

BioSpace

Vifor Pharma Group and Travere Therapeutics inked a collaborationfor the commercialization of sparsentan for the treatment rare progressive kidney diseases

Moderna to collaborate with AbCellera

Pharma Times

Partnership aims to develop mRNA-encoded antibody therapeutics

Seven Companies Present Exciting News at ESMO 2021

BioSpace

Biopharma companies big and small are presenting exciting clinical studies at the European Society for Medical Oncology Congress 2021

83

BioCryst’s HAE med Orladeyo wins NICE nod

Pharma Times

NICE has recommended the treatment for people who have at least two attacks per month

82

Novo Nordisk, Broad Institute Partner to Uncover Genetic Links to Disease

BioSpace

The massive genetic data mining project aims to gain deeper insight into how human genetic variants affect risk for common complex diseases

Pfizer's mRNA flu vaccine candidate set to enter clinic

BioPharma Reporter

Pfizerâs mRNA flu vaccine joins candidates from Moderna and Sanofi in hoping to provide greater protection against influenza than existing vaccines. Bio Developments

COVID-19 Cements Science Journalism’s Place as a Top News Priority

BioSpace

The COVID-19 pandemic has changed science journalism. Semantics aside, though, science and health care have taken a new position in the hierarchy of top news priorities

82

AGC Biologics invests in Germany to address booming mRNA industry

BioPharma Reporter

AGC Biologics is expanding its Heidelberg facility to create new capacity for messenger RNA (mRNA) projects, and to boost its plasmid-DNA (pDNA) manufacturing capabilities. Upstream Processing

RNA 80

COVID-19 Update: Remdesivir Questioned, Booster Meeting and a New Intranasal Vaccine

BioSpace

?COVID-19 remains relentless in challenging the community as it continues to evolve. Here are some of the top news for the week

Rare-disease initiative collaborators work to advance research innovation

Outsourcing Pharma

Stakeholders in the Rare Disease Cures Accelerator-Data and Analytics Platform initiative are partnering in hopes of bringing treatments to patients faster. Clinical Development

EQRx and CStone Tout Data from Trial of Firsts at ESMO 2021

BioSpace

In a late-breaking presentation on Saturday, EQRx and partner CStone Pharmaceuticals will report data from the phase III GEMSTONE-301 study of its anti-PD-L1 antibody sugemalimab

Here’s What Happens When Food and Cryptocurrency Collide

XTalks

Invented in 2009, Bitcoin, the first decentralized cryptocurrency, has paved the way for the launch of more than 4,000 cryptocurrencies.

DOJ Pushes Back on Purdue Settlement that Would Shield Sackler Family

BioSpace

A trustee with the DOJ filed a request for an “expedited stay” in order to prevent the initiation of the bankruptcy plan

81

TILT Biotherapeutics Announces Data at ESMO on Its Oncolytic Immunotherapy Platform

BioTech 365

NC Fought Hard for Gilead’s New Site, Adding to Exploding Biotech Presence

BioSpace

Gilead announced its plans to replant some roots back in North Carolina’s Research Triangle. The new site is expected to bring in 275 jobs to the North Hills innovation district

Advocates to Protest Congressman Scott Peters for Vote Against Rx Price Negotiations

BioTech 365

Advocates to Protest Congressman Scott Peters for Vote Against Rx Price Negotiations Advocates to Protest Congressman Scott Peters for Vote Against Rx Price Negotiations San Diego District Office Protest – Friday, September 17, 11:00 am Peters voted yesterday against a … Continue reading → Business Wire

52

Studying thermophoresis in space

Scienmag

It’s the rare engineer who gets to conduct experiments in space. But Lehigh University now has three who will be doing just that. Credit: Lehigh University It’s the rare engineer who gets to conduct experiments in space. But Lehigh University now has three who will be doing just that.

Tarveda Therapeutics and SciClone Pharmaceuticals Expand Partnership by Entering into a License Agreement for HSP90-PI3K Miniature Drug Conjugates in Greater China

BioTech 365

New cell type in human skin discovered to contribute to inflammatory skin diseases like atopic dermatitis and psoriasis

Scienmag

A team of international scientists and clinical experts have unravelled a new cell type in human skin that contributes to inflammatory skin diseases such as atopic dermatitis (AD) and psoriasis (PSO). Their study findings were published in the Journal of Experimental Medicine in September 2021.

Emergency Use Authorization of AbCellera-Discovered Bamlanivimab Administered with Etesevimab Expanded by the FDA to Include Post-Exposure Prophylaxis for the Prevention of COVID-19

BioTech 365

52

Long COVID symptoms in children rarely persist beyond 12 weeks

Scienmag

Long COVID symptoms rarely persisted beyond 12 weeks in children and adolescents unlike adults.

Life Sciences BC Board of Directors Announcement

BioTech 365

Life Sciences BC Board of Directors Announcement Life Sciences BC Board of Directors Announcement VANCOUVER, British Columbia–(BUSINESS WIRE)–#BCbiotech–Following a well-attended AGM, Life Sciences BC is pleased to announce new Board of Directors members, with thanks to those who are departing.

Patients and non-oncology doctors struggle to keep up with the pace of change in oncology, research shows

Scienmag

Suicide Risk Assessment in Clinical Trial Drug Development: Part 1

ERT

Kelly Posner, Ph.D., Professor of Psychiatry at Columbia University. John Greist, MD, Professor Emeritus of Psychiatry at the University of Wisconsin School of Medicine and Public Health and CEO at Healthcare Technology Systems, Inc. James Mundt, Ph.D., Consultant.

Median Technologies Has Been Confirmed as a Preferred Vendor by one of the Top 3 Pharmaceutical Companies in the World, and Selected to Implement Their Clinical Trial Imaging Strategy on Some Key Oncology Indications

BioTech 365

Median Technologies Has Been Confirmed as a Preferred Vendor by one of the Top 3 Pharmaceutical Companies in the World, and Selected to Implement Their Clinical Trial Imaging Strategy on Some Key Oncology Indications Median Technologies Has Been Confirmed as … Continue reading → Business Wire

MAIT cell activation may play a role in fatal outcomes among severe COVID-19 cases

Scienmag

The mortality rate of COVID-19 patients requiring mechanical ventilation is 30-40%, however, the immunological factors associated with death in critically ill COVID-19 patients are poorly understood. A study published in PLOS Pathogens by Jonathan Youngs at St.

52